Considering the relationship between serum compounds and myelofibrosis characteristics, JAK2 mutated PMFs (as mentioned, present in about 60% of cases) show a lower creatinine value and higher xanthine and MDA, evidencing a potential role of hyperactivated JAK-STAT pathway in the oxidative stress in these patients. The gene discussed is JAK2; the disease is myelofibrosis.